FDA meetings
This article was originally published in The Tan Sheet
Executive Summary
FDA's first public meeting has been postponed and will be rescheduled at a later date due to "the need to focus on Hurricane Katrina relief efforts," the agency announced Sept. 8. The meeting, originally scheduled for Sept. 13 in Miami, Fla., is the first in a three-part series entitled, "Vision 2006 - A Conversation with the American Public." Designed as an open forum where FDA can update the public on agency programs and engage in public discussion, the meetings are expected to be attended by Commissioner Lester Crawford and other top leadership ("1The Tan Sheet" Aug. 22, 2005, p. 9)....
You may also be interested in...
FDA “Top Leadership” Will Attend Public Meetings Seeking Consumer Insight
The "safety and reliability" of dietary supplements is one of several topics that will be addressed during an upcoming series of public meetings hosted by FDA
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.